In 2023, measles cases rose 20% globally and immunization rates fell far below the 95% threshold needed to prevent outbreaks. A promising nasal spray therapy targeting neuroinflammation shows potential to delay Alzheimer’s progression by 10–15 years, according to a study leveraging neural stem cell-derived extracellular vesicles. Additionally, a phase 1 trial of neoantigen DNA vaccines in triple-negative breast cancer demonstrated safety and effectiveness.
